Table 4.
Bivariable analysis | Multivariable analysis | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
HR | 95% CI | p value | HR | 95% CI | p value | |||
NACT received | ||||||||
No | 1.00 | |||||||
Yes | 0.62 | 0.41 | 0.95 | 0.026 | ||||
NACT consult | ||||||||
No | 1.00 | |||||||
Yes | 0.72 | 0.53 | 0.97 | 0.030 | ||||
Location | ||||||||
Edmonton | 1.00 | |||||||
Calgary | 1.08 | 0.81 | 1.43 | 0.609 | ||||
Year of diagnosis | ||||||||
Per year | 1.02 | 0.92 | 1.14 | 0.706 | ||||
Pathologic stage post-cystectomy | ||||||||
≤pT1 | 1.00 | 1.00 | ||||||
≥pT2 | 3.98 | 2.53 | 6.25 | <0.001 | 3.74 | 2.43 | 5.77 | <0.001 |
Sex | ||||||||
Male | 1.00 | |||||||
Female | 0.80 | 0.59 | 1.07 | 0.124 | ||||
Annual surgeon case load | ||||||||
≤1.5 | 1.00 | 0.400 | ||||||
1.6–2.5 | 0.65 | 0.39 | 1.07 | |||||
2.6–6.0 | 0.82 | 0.54 | 1.24 | |||||
>6.0 | 0.86 | 0.57 | 1.30 | |||||
Age | ||||||||
<60 | 1.00 | 0.002 | 1.00 | |||||
60–69 | 1.41 | 0.81 | 2.44 | 1.48 | 0.90 | 2.44 | 0.121 | |
70–79 | 1.68 | 1.04 | 2.71 | 1.58 | 1.02 | 2.44 | 0.041 | |
≥80 | 2.84 | 1.67 | 4.83 | 2.48 | 1.45 | 4.20 | 0.001 |
NACT: neoadjuvant chemotherapy; OR: odds ratio; CI: confidence interval.